DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the approval of the company’s upcoming 15-day G7 continuous glucose monitor (CGM).

New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

Who sprayed Ilhan Omar? What was she sprayed with at town hall? What we know China executes 11 members of gang who ran billion-dollar criminal empire in Myanmar Economist warns coming financial crisis ...

Halloween was a few days ago, but don't throw out those pumpkins. There are lots ways to reuse your pumpkins or jack-o’-lanterns now that the trick-or-treating is done. If you didn't carve the ...

Sense – analyze – act. This is the principle that advanced driver assistance systems (ADAS) operate on. Modern vehicles rely on a network of sensors to build a more precise, reliable perception of ...

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...

Geneva, Switzerland -- Acquisition boosts ST’s position in automotive safety and expands leadership in sensors across automotive and industrial end markets STMicroelectronics (NYSE: STM), a global ...

Looking for an alarm system to make you feel more secure? We've tested all the top professional and DIY home security systems to help you decide which is right to protect your family and property.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...